Skip to content
Review

Animal Virus Evolution under Vaccine Pressure: From Immune Escape Mechanisms to Next-Generation Vaccine Design

Jul 2026 · SAR Journal of Pathology and Microbiology · 0 citations

TL;DR

The review emphasizes the necessity of global surveillance programs to monitor viral evolution in real-time and calls for a collaborative, interdisciplinary approach to create more robust and future-proof vaccination strategies, thereby mitigating the risk of vaccine-driven viral and ensuring long term efficacy.

Abstract

This review examines the critical challenge of evolving animal virus resistance to vaccines, a phenomenon threatening veterinary medicine, global food security, and public health. While effective for controlling bacterial diseases, vaccination against rapidly mutating RNA viruses often imposes strong selective pressures, driving the emergence of antigenic variants that evade host immunity. These vaccines escape mutants, evidenced in viruses like canine parvovirus (CPV), avian influenza (AIV), and foot-and-mouth disease (FMD), lead to outbreaks in vaccinated populations and complicate disease management. The paper elucidates the mechanisms behind this resistance, primarily genetic mutations in antigenic sites and sophisticated immune evasion strategies, which enable viruses to circumvent neutralization by vaccine-induced antibodies. It critically evaluates the limitations of current vaccine technologies, including inactivated, live-attenuated, and subunit vaccines, noting that imperfect immunity can inadvertently promote the selection of resistant strains. To address this ongoing evolutionary arms race, the authors advocate for a paradigm shift in vaccine design. They propose leveraging advanced technologies such as viral vector platforms, structural biology, and predictive modeling to develop next-generation vaccines targeting conserved epitopes. Furthermore, the review emphasizes the necessity of global surveillance programs to monitor viral evolution in real-time and calls for a collaborative, interdisciplinary approach to create more robust and future-proof vaccination strategies, thereby mitigating the risk of vaccine-driven viral and ensuring long term efficacy.

View source

Similar papers

Review Open access Jul 2026

Counteracting Influenza Virus Evolution Through the Full Spectrum of Broadly Protective Antibodies

Current knowledge of broadly protective flu antibodies is summarized and how mechanistic and structural insights can guide the development of next‐generation influenza vaccines that offer broad‐spectrum protection against antigenically diverse viruses is discussed.

Yu Adachi, Yoshimasa Takahashi · 1 citation
Review Open access Aug 2026

Antiviral strategies against human norovirus: Molecular targets, therapeutics, and vaccine development

This review provides a critical analysis of the molecular mechanisms governing HuNoV infection, immune evasion, and replication, with a focused emphasis on key antiviral targets, inhibitory strategies, and therapeutic development.

Sadia Islam, Sabbir Zia, Simonto Mirza et al. · 0 citations
Open access Aug 2026

A bivalent inactivated influenza vaccine incorporating epitope-optimized surface proteins confers cross-protective immunity against H9N2 influenza virus

A bivalent chimeric inactivated vaccine, designated cHANA, is developed by combining two individually rescued chimeric inactivated viruses, cHANA1 and cHANA2, by combining two individually rescued chimeric inactivated viruses to eliciting more potent cross-reactive antibody responses and T cell immunity in mice.

Mengchan Hao, Yiwei Guan, Meng Xu et al. · 0 citations
Review Open access Jul 2026

Swine Group A rotavirus vaccines: current status, adjuvant strategies, challenges, and future perspectives

This review analyzes the potential contribution of adjuvant strategies to developing a universal porcine rotavirus vaccine capable of broad, long-lasting cross-protection and identifies key unresolved scientific questions and critical knowledge gaps in the field with the aim of guiding future research priorities.

Zhen Zhang, Baihe Ma, Hong-Miao Zhou et al. · 0 citations
Open access Jan 2026

Adaptive Evolution of Serotype O Foot‐and‐Mouth Disease Virus Under Vaccine Pressure: Combined VP1 T142/Q153 Mutations Drive Antigenic Alteration and Immune Evasion

Combined mutations at VP1 142 and 153 reshape viral antigenicity and act as core drivers of FMDV immune evasion, offering an experimental basis for clarifying FMDV evolution and developing broad‐spectrum vaccines.

Nan Cao, Ya-Mei Li, Xing-Hua Chen et al. · 0 citations
Review Open access Jul 2026

Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control

This review comprehensively evaluates the rational design of classical animal herpesvirus vectors, including pseudorabies virus, herpesvirus of turkeys, and feline herpesvirus type 1, providing perspectives on how continuous biotechnological innovations will empower herpesvirus vectors to serve as formidable prophylact...

Jia-Hui Guo, Chen Mei, Xin-Yao Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.